IBB vs. SCHY
IBB (iShares Nasdaq Biotechnology ETF) and SCHY (Schwab International Dividend Equity ETF) are both exchange-traded funds - IBB is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index, while SCHY is a Dividend fund tracking the Dow Jones International Dividend 100 Index. Both are passively managed. Over the past 5 years, IBB returned 2.78%/yr vs 8.63%/yr for SCHY. A 0.51 correlation means they provide meaningful diversification when combined. IBB charges 0.47%/yr vs 0.08%/yr for SCHY.
Performance
IBB vs. SCHY - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with IBB having a 10.62% return and SCHY slightly lower at 10.12%.
IBB
- 1D
- -1.70%
- 1M
- 7.42%
- 6M
- 9.84%
- YTD
- 10.62%
- 1Y
- 44.15%
- 3Y*
- 12.68%
- 5Y*
- 2.78%
- 10Y*
- 7.41%
- ALL TIME*
- 7.17%
SCHY
- 1D
- -0.80%
- 1M
- 2.12%
- 6M
- 8.67%
- YTD
- 10.12%
- 1Y
- 23.00%
- 3Y*
- 14.24%
- 5Y*
- 8.63%
- 10Y*
- —
- ALL TIME*
- 8.76%
IBB vs. SCHY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 10.62% | 27.98% | -2.41% | 3.76% | -13.69% | -2.54% |
SCHY Schwab International Dividend Equity ETF | 10.12% | 33.98% | -1.79% | 14.27% | -9.43% | 3.42% |
Correlation
The correlation between IBB and SCHY is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.49 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.51 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.51 |
Correlation (All Time) Calculated using the full available price history since Apr 29, 2021 | 0.51 |
The correlation between IBB and SCHY has been stable across timeframes, ranging from 0.49 to 0.51 - a consistent structural relationship.
IBB vs. SCHY - Sectors Allocation Comparison
Sectors
IBB
SCHY
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
IBB
SCHY
Basic Materials
IBB
-
SCHY
Communication Services
IBB
-
SCHY
Consumer Cyclical
IBB
-
SCHY
Consumer Defensive
IBB
-
SCHY
Energy
IBB
-
SCHY
Financial Services
IBB
-
SCHY
Industrials
IBB
-
SCHY
Real Estate
IBB
-
SCHY
Technology
IBB
-
SCHY
Utilities
IBB
-
SCHY
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBB vs. SCHY — Risk / Return Rank
IBB
SCHY
IBB vs. SCHY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and Schwab International Dividend Equity ETF (SCHY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBB | SCHY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.25 | ||
| Sortino ratioReturn per unit of downside risk | +0.37 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.34 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 4.60 | 2.54 | +2.07 |
| Martin ratioReturn relative to average drawdown | 13.90 | 7.20 | +6.69 |
Loading charts...
Drawdowns
IBB vs. SCHY - Drawdown Comparison
The maximum IBB drawdown since its inception was -62.85%, which is greater than SCHY's maximum drawdown of -24.04%. Use the drawdown chart below to compare losses from any high point for IBB and SCHY.
Loading charts...
Drawdown Indicators
| IBB | SCHY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.85% | -24.04% | -38.81% |
Max Drawdown (1Y)Largest decline over 1 year | -9.63% | -9.11% | -0.52% |
Max Drawdown (3Y)Largest decline over 3 years | -24.85% | -12.16% | -12.69% |
Max Drawdown (5Y)Largest decline over 5 years | -39.82% | -24.04% | -15.78% |
Max Drawdown (10Y)Largest decline over 10 years | -39.82% | — | — |
Current DrawdownCurrent decline from peak | -5.90% | -3.22% | -2.68% |
Average DrawdownAverage peak-to-trough decline | -21.09% | -4.95% | -16.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.19% | 3.20% | -0.01% |
Volatility
IBB vs. SCHY - Volatility Comparison
iShares Nasdaq Biotechnology ETF (IBB) has a higher volatility of 6.21% compared to Schwab International Dividend Equity ETF (SCHY) at 2.87%. This indicates that IBB's price experiences larger fluctuations and is considered to be riskier than SCHY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBB | SCHY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.21% | 2.87% | +3.34% |
Volatility (6M)Calculated over the trailing 6-month period | 15.93% | 10.23% | +5.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.51% | 12.08% | +8.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.14% | 13.25% | +8.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.13% | 13.19% | +9.94% |
IBB vs. SCHY - Expense Ratio Comparison
IBB has a 0.47% expense ratio, which is higher than SCHY's 0.08% expense ratio.
Dividends
IBB vs. SCHY - Dividend Comparison
IBB's dividend yield for the trailing twelve months is around 0.22%, less than SCHY's 3.43% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 0.22% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
SCHY Schwab International Dividend Equity ETF | 3.43% | 3.55% | 4.64% | 3.97% | 3.67% | 1.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IBB and SCHY have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBB has higher volatility (6.21%) compared to SCHY (2.87%). In terms of maximum drawdown, IBB dropped -62.85% vs SCHY's -24.04%.
On 5-year performance, SCHY leads with 8.63% vs 2.78% for IBB. On fees, SCHY is cheaper at 0.08% per year. On volatility, SCHY has been the lower-risk option at 2.87%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, SCHY has performed better with a 8.63% return vs 2.78%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SCHY is cheaper with a 0.08% expense ratio, compared with 0.47% for IBB.
SCHY has the higher dividend yield at 3.43%, compared with 0.22% for IBB.
IBB is categorized as Health & Biotech Equities, while SCHY is Dividend. IBB tracks NASDAQ Biotechnology Index, while SCHY tracks Dow Jones International Dividend 100 Index. They also come from different issuers: iShares and Charles Schwab. Their fees differ too: 0.47% for IBB and 0.08% for SCHY.
IBB currently has the higher Sharpe Ratio (2.17 vs 1.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBB and SCHY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer